OptiNose Inc OPTN.OQ OPTN.O is expected to show a rise in quarterly revenue when it reports results on March 20 for the period ending December 31 2024
The Yardley Pennsylvania-based company is expected to report a 12.3% increase in revenue to $22.307 million from $19.87 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on November 12 2024, for the period ended December 31, was for revenue between $19.00 million and $23.00 million.
LSEG's mean analyst estimate for OptiNose Inc is for a loss of 72 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for OptiNose Inc is $17.50, above its last closing price of $5.88.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.79
-0.79
0.00
Beat
100
Jun. 30 2024
-1.11
-1.16
-0.75
Beat
35.3
Mar. 31 2024
-1.63
-1.61
-1.80
Missed
-11.6
Dec. 31 2023
-1.42
-1.41
-1.35
Beat
4.6
Sep. 30 2023
-1.42
-1.41
-1.20
Beat
15.2
Jun. 30 2023
-1.61
-1.63
0.30
Beat
118.4
Mar. 31 2023
-2.06
-2.09
-2.55
Missed
-22
Dec. 31 2022
-2.60
-2.62
-2.55
Beat
2.7
This summary was machine generated March 18 at 12:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)